Geben Sie eine Aktie oder eine Kryptowährung in der Suchleiste an, um eine Zusammenfassung zu erhalten
AddLife AB (publ)
ALIF-BAddLife AB (publ), together with its subsidiaries, provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates through Labtech and Medtech segments. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory equipment for plastic consumables, cell biology, reagents, lab, and other instruments. The Medtech segment provides medical device products for surgery, thoracic medicine, neurology, wound care, anaesthesia, intensive care, ear, nose and throat, ostomies, and home healthcare, as well as assistive technology for senior citizens and disabled children. It operates in Sweden, the United Kingdom, Ireland, Spain, Denmark, Norway, Italy, Finland, Switzerland, Germany, rest of Europe, and internationally. AddLife AB (publ) was founded in 1906 and is based in Stockholm, Sweden. Address: Brunkebergstorg 5, Stockholm, Sweden, 103 62
Analytics
Zielpreis von Wall Street
1 704.43 SEKKGV
146.5625Dividendenrendite
0.38 %Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Laufendes Jahr
Letztes Jahr
Laufendes Quartal
Letztes Quartal
Schlüsselzahlen ALIF-B
Dividenden-Analyse ALIF-B
Dividendenwachstum über 5 Jahre
–Kontinuierliches Wachstum
2 JahreAusschüttungsquote 5-Jahres-Durchschnitt
33 %Verlauf der Dividende ALIF-B
Bewertung der Aktie ALIF-B
Finanzen ALIF-B
Ergebnisse | 2019 | Dynamik |